Fuse Medical, Inc. FZMD
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -5.77% | -11.95% | -8.67% | -7.26% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.77% | -11.95% | -8.67% | -7.26% | -- |
| Cost of Revenue | -21.11% | -16.93% | -11.24% | -11.46% | -- |
| Gross Profit | 5.27% | -8.52% | -6.85% | -4.32% | -- |
| SG&A Expenses | -8.84% | -16.29% | -13.11% | -2.51% | -- |
| Depreciation & Amortization | -42.90% | -28.25% | -8.12% | 156.95% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.65% | -16.57% | -12.39% | -5.55% | -- |
| Operating Income | 88.36% | 59.63% | 47.04% | -30.11% | -- |
| Income Before Tax | 299.75% | 289.77% | 276.65% | -11.50% | -- |
| Income Tax Expenses | 42.47% | 34.62% | 34.46% | 9.80% | -- |
| Earnings from Continuing Operations | 296.33% | 286.12% | 273.21% | -11.48% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 296.33% | 286.12% | 273.21% | -11.48% | -- |
| EBIT | 88.36% | 59.63% | 47.04% | -30.11% | -- |
| EBITDA | 97.08% | 66.71% | 54.07% | -21.25% | -- |
| EPS Basic | 296.58% | 286.46% | 273.01% | -11.49% | -- |
| Normalized Basic EPS | 79.27% | 52.94% | 41.58% | -35.05% | -- |
| EPS Diluted | 237.64% | 220.96% | 206.64% | -1.85% | -- |
| Normalized Diluted EPS | 84.97% | 59.80% | 48.51% | -35.05% | -- |
| Average Basic Shares Outstanding | -0.07% | -0.04% | 0.00% | 0.25% | -- |
| Average Diluted Shares Outstanding | 13.38% | 10.68% | 10.72% | 0.25% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |